Related Experiment Video
Updated: Jul 18, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Short-term results under three different immunosuppressive regimens at one center
H M Schaefer1, A Tarik Kizilisik, I Feurer
1Division of Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4750, USA.
Transplantation Proceedings
|December 19, 2006
Summary
Kidney transplant patients on a prednisone-free immunosuppression regimen showed better glucose and lipid levels. This approach offers comparable graft survival and rejection rates to standard or calcineurin inhibitor-free (CNI) therapies.
Area of Science:
- Nephrology
- Transplant Immunology
- Immunosuppression Therapy
Background:
- Optimizing immunosuppressive strategies post-kidney transplantation is crucial for long-term graft survival and minimizing patient morbidity.
- Standard triple therapy often includes calcineurin inhibitors (CNIs), prednisone, and mycophenolate mofetil, but can be associated with significant side effects.
- Alternative regimens aim to reduce toxicity while maintaining efficacy.
Purpose of the Study:
- To compare short-term outcomes and posttransplant medical complications of three distinct immunosuppressive regimens in kidney transplant recipients.
- To evaluate a calcineurin inhibitor-free (CNI) protocol against standard triple therapy and a prednisone-free protocol.
Main Methods:
- A randomized, prospective, open-label trial was conducted.
- Three groups were compared: CNI-free protocol, standard triple therapy (tacrolimus, prednisone, mycophenolate mofetil), and a nonrandomized prednisone-free protocol.
- Outcomes assessed included patient and graft survival, biopsy-proven acute rejection, serum creatinine, lipid panels, and posttransplant diabetes mellitus.
Main Results:
- All three immunosuppressive regimens demonstrated excellent early outcomes with no significant differences in patient or graft survival or acute rejection rates.
- Serum creatinine levels were significantly lower in the CNI-free group.
- Prednisone-free recipients showed significantly lower rates of posttransplant diabetes mellitus and improved lipid profiles.
Conclusions:
- Kidney transplantation using a prednisone-free immunosuppressive protocol leads to improved early glucose metabolism and reduced hyperlipidemia.
- These benefits are achieved with comparable rejection rates and graft survival compared to CNI-free or standard triple therapy regimens.
- The prednisone-free approach represents a promising alternative for optimizing post-kidney transplant management.
